FDA Finally Blinks on Sunscreen

Americans have been slathering on the same sunscreen ingredients for over two decades — but that just changed, and the new option has already been protecting skin in Europe for years.

Quick Take

The Food and Drug Administration (FDA) added bemotrizinol as a permitted sunscreen ingredient in June 2026, the first new addition in more than 20 years.
Bemotrizinol blocks both UVA and UVB rays and has been used safely in European sunscreens for decades.
The FDA reviewed safety and effectiveness data before clearing the ingredient for over-the-counter use in the U.S.
Products with bemotrizinol won’t hit store shelves instantly — manufacturers must still meet labeling and formulation rules before selling them.

Why It Took Over 20 Years to Get Here

The U.S. sunscreen market has been stuck in a regulatory time warp. While European consumers had access to newer, more advanced sun filters, Americans were limited to ingredients approved before 2000.

The FDA regulates sunscreen as an over-the-counter drug, not a cosmetic, which means any new active ingredient must clear a formal review process. That process is thorough — but it has also been painfully slow. ^[1]

The U.S. just got its first new sunscreen in almost 20 years. Bemotrizinol is a powerful, broad-spectrum blocker of dangerous rays that has been used in Europe for years. https://t.co/DWxQ77SZYa pic.twitter.com/x3vuvyhGc5

— Yahoo News (@YahooNews) June 10, 2026

Bemotrizinol is an oil-soluble chemical filter that absorbs ultraviolet light across a wide range of wavelengths. That means it tackles both UVA rays, which age skin and drive deeper damage, and UVB rays, which cause sunburn. Most older U.S. sunscreen ingredients handle one type better than the other. Bemotrizinol handles both well, which is a real upgrade in protection. ^[9]

What the FDA Actually Reviewed Before Saying Yes

The FDA did not simply wave this through. The agency reviewed clinical pharmacokinetic data — studies that track how much of a substance enters the bloodstream through skin — along with safety and effectiveness evidence gathered over years of use abroad. ^[10]

The FDA’s own scientific review concluded that bemotrizinol meets the standard of being generally recognized as safe and effective for sunscreen use at tested concentrations. ^[11] That is a high bar, and bemotrizinol cleared it.

The American Academy of Dermatology Association backed the FDA’s move, calling it a step forward for public health and sun protection options. ^[6]

Dermatologists have long argued that the U.S. was behind other developed nations in giving consumers access to better-performing filters. Skin cancer is the most common cancer in the United States, so expanding the tools available to prevent it is a straightforward win. ^[7]

Don’t Expect It on Shelves Tomorrow

Here is where the story gets more nuanced. The FDA adding bemotrizinol to the permitted ingredients list does not mean products appear overnight. ^[5]

Once the final order takes effect, each manufacturer decides whether to use the ingredient, then must formulate, test, and label their product correctly before it goes to market. That takes time. Think of it as the FDA opening a door — companies still have to walk through it. ^[5]

Caption

🚨 Big sunscreen news: for the first time in 20 years, the FDA just approved a brand-new sunscreen ingredient called bemotrizinol (aka BEMT).

Why it matters for your skin:
☀️ Stronger UVA protection, and those are the rays that drive aging and skin cancer (most US… pic.twitter.com/8Awxhye4Vr

— Dr Doris Day (@DrDorisDay) June 9, 2026

It also helps to understand how the FDA’s over-the-counter monograph system works. A monograph is essentially a rulebook for a category of drugs sold without a prescription.

When the FDA updates a monograph to add a new active ingredient, it is changing the rulebook for every sunscreen maker at once. That is different from approving a single brand-name drug. The process is slower and more complex, but the reach is far wider. ^[3]

What This Means for Your Sunscreen Routine

For now, keep using what works. A broad-spectrum sunscreen with SPF 30 or higher, applied generously and reapplied every two hours, still does the job. Zinc oxide and titanium dioxide remain solid choices, especially for sensitive skin. ^[8]

But when bemotrizinol-based products reach shelves, they will offer a lighter, more cosmetically elegant option that many people may find easier to wear daily — and a sunscreen you’ll actually use beats a perfect one you leave in the cabinet.

The bottom line is simple. The FDA moved carefully, reviewed the data, and made a sound call. Europe ran the long experiment first, and the results were good. American consumers deserve access to the best sun protection available, and after more than 20 years of waiting, they are finally getting it. ^[1]